Clinical Trial Update: Randomized Study of Two Doses of Oral Valacyclovir in Immunocompromised Patients With Uncomplicated Herpes Zoster [NA]

View source ↗

Summary

A completed randomized trial compared two oral doses of valacyclovir in immunocompromised patients with uncomplicated herpes zoster.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Herpes Zoster
• Immunodeficiency

Drugs mentioned

• Valacyclovir (Valacyclovir)

Snippet

Sponsor: National Center for Research Resources (NCRR) | Conditions: Herpes Zoster, Immunologic Deficiency Syndromes | NA | Status: COMPLETED